ALGN vs. WST
Compare and contrast key facts about Align Technology, Inc. (ALGN) and West Pharmaceutical Services, Inc. (WST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ALGN or WST.
Correlation
The correlation between ALGN and WST is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ALGN vs. WST - Performance Comparison
Loading data...
Key characteristics
ALGN:
-0.86
WST:
-0.69
ALGN:
-1.29
WST:
-0.75
ALGN:
0.85
WST:
0.86
ALGN:
-0.46
WST:
-0.69
ALGN:
-1.60
WST:
-1.95
ALGN:
22.99%
WST:
21.01%
ALGN:
40.88%
WST:
54.87%
ALGN:
-92.80%
WST:
-59.29%
ALGN:
-76.45%
WST:
-55.28%
Fundamentals
ALGN:
$13.23B
WST:
$15.48B
ALGN:
$5.51
WST:
$6.38
ALGN:
33.14
WST:
33.77
ALGN:
0.99
WST:
3.62
ALGN:
3.32
WST:
5.34
ALGN:
3.49
WST:
5.77
ALGN:
$3.98B
WST:
$2.90B
ALGN:
$2.78B
WST:
$1.00B
ALGN:
$804.14M
WST:
$729.50M
Returns By Period
In the year-to-date period, ALGN achieves a -17.55% return, which is significantly higher than WST's -36.11% return. Over the past 10 years, ALGN has underperformed WST with an annualized return of 11.23%, while WST has yielded a comparatively higher 14.73% annualized return.
ALGN
-17.55%
-0.18%
-23.21%
-34.89%
-14.50%
-6.74%
11.23%
WST
-36.11%
1.59%
-32.85%
-37.82%
-11.19%
0.00%
14.73%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ALGN vs. WST — Risk-Adjusted Performance Rank
ALGN
WST
ALGN vs. WST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Align Technology, Inc. (ALGN) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ALGN vs. WST - Dividend Comparison
ALGN has not paid dividends to shareholders, while WST's dividend yield for the trailing twelve months is around 0.40%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALGN Align Technology, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
WST West Pharmaceutical Services, Inc. | 0.40% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% |
Drawdowns
ALGN vs. WST - Drawdown Comparison
The maximum ALGN drawdown since its inception was -92.80%, which is greater than WST's maximum drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for ALGN and WST. For additional features, visit the drawdowns tool.
Loading data...
Volatility
ALGN vs. WST - Volatility Comparison
Align Technology, Inc. (ALGN) has a higher volatility of 11.68% compared to West Pharmaceutical Services, Inc. (WST) at 10.00%. This indicates that ALGN's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ALGN vs. WST - Financials Comparison
This section allows you to compare key financial metrics between Align Technology, Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ALGN vs. WST - Profitability Comparison
ALGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Align Technology, Inc. reported a gross profit of 680.11M and revenue of 979.26M. Therefore, the gross margin over that period was 69.5%.
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a gross profit of 231.90M and revenue of 698.00M. Therefore, the gross margin over that period was 33.2%.
ALGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Align Technology, Inc. reported an operating income of 131.10M and revenue of 979.26M, resulting in an operating margin of 13.4%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported an operating income of 107.00M and revenue of 698.00M, resulting in an operating margin of 15.3%.
ALGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Align Technology, Inc. reported a net income of 93.23M and revenue of 979.26M, resulting in a net margin of 9.5%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a net income of 89.80M and revenue of 698.00M, resulting in a net margin of 12.9%.